Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911151 | Lung Cancer | 2014 | 8 Pages |
Abstract
NF-κB IHC was a modest biomarker of prognosis that associated with tumor glucose metabolism on FDG PET when compared to existing molecular correlates like LDHA, which was synergistic with NF-κB for outcome. These findings recapitulate radiogenomics profiles previously reported by our group and provide a methodology for studying tumor biology using computational approaches.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Viswam S. Nair, Olivier Gevaert, Guido Davidzon, Sylvia K. Plevritis, Robert West,